Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,377 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07309211Recruiting
Durvalumab as maintenance therapy for limited-stage small cell lung cancer
This trial is for people with limited-stage small cell lung cancer who have already finished chemotherapy and radiation, and then started taking Durvalumab (Imfinzi) as a maintenance therapy. The goal is to see if continuing Durvalumab helps keep the cancer from coming back.
JinanAges 18 years+ - NCT07309276RecruitingPhase 2
Study of JS212 for advanced lung cancer
This trial tests a new drug called JS212 combined with other treatments for people with advanced or spreading lung cancer. It aims to see if the combination can help shrink tumors or slow the disease.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07328711RecruitingEarly Phase 1
Immunotherapy for chronic hepatitis B after HBsAg loss
This trial tests an immunomodulatory therapy for people with chronic hepatitis B who have already cleared the surface antigen (HBsAg) with a specific treatment. It aims to understand why some people achieve a cure and how to improve outcomes.
Beijing, Beijing MunicipalityAges 18–60 - NCT07376629Enrolling by invitationPhase 2
Study of HB0025 plus nab-paclitaxel for first-line TNBC
This trial tests a new drug (HB0025) combined with chemotherapy (nab-paclitaxel) as the first treatment for people with triple-negative breast cancer that has spread or cannot be removed by surgery. It aims to see if this combination works better than standard care.
AnyangAges 18–75 - NCT05456035Recruiting
Talk-therapy plus social skills training for depressed teens
This study tests whether adding social-cognitive training (skills for understanding social situations and thoughts) to regular talk therapy helps teens with depression. It may help improve mood and daily functioning compared with talk therapy alone.
Nashville, TennesseeAges 13–17 - NCT06802406Recruiting
Nutrition support for transplant or cell therapy patients
This study tests a program to help patients who are getting a transplant or cell therapy and have trouble getting enough food. It provides nutrition resources to improve their health during treatment.
Stanford, CaliforniaAges 8–80 - NCT05179655Recruiting
Parent-focused program for teens who self-harm
This trial studies a program for teens and their parents to help reduce non-suicidal self-injury. It may help families learn skills and support that prevent self-harm from continuing or worsening.
AalborgAges 13–17 - NCT06969859Recruiting
Pulsed electromagnetic field therapy for Achilles tendon pain
This study tests if pulsed electromagnetic field (PEMF) therapy can help people with mid-portion Achilles tendinopathy (pain and swelling in the middle of the Achilles tendon). It aims to see if this non-invasive treatment can reduce pain and improve function.
Shatin, New TerritoriesAges 18 years+ - NCT04552080RecruitingPhase 4
Antibiotics around sinus and bone graft implants to prevent problems
This trial studies whether taking antibiotics through the body (systemic antibiotics) after sinus-lift and bone-graft dental implant surgery can reduce post-surgery complications and improve patient comfort. It compares outcomes that matter to patients after implant placement using guided bone regeneration and a sinus floor elevation.
GrazAges 21 years+ - NCT06104176Recruiting
Virtual reality therapy for alcohol use disorder
This study tests if virtual reality therapy can help people with alcohol use disorder stay abstinent. You must be sober for at least 15 days to participate.
Créteil, Île-de-France RegionAges 18–80 - NCT06503497RecruitingEarly Phase 1
NK cell therapy for pancreatic cancer after standard treatment
This trial tests a new therapy using your own immune cells (NK cells) that are specially trained to find and attack cancer cells. It is for people with pancreatic cancer that has not responded to previous treatment.
Hangzhou, ZhejiangAges 18–75 - NCT07286253RecruitingPhase 2
QL1706 plus chemo before surgery for advanced cervical cancer
This trial is testing whether adding the immunotherapy drug QL1706 to standard chemotherapy before surgery can improve outcomes for women with a certain type and stage of cervical cancer. It is for women whose cancer has not been treated yet and who are healthy enough for the treatment.
Guangzhou, GuangdongAges 18–70 - NCT06502626Recruiting
Sprint interval training for field hockey players
This trial tests whether short, intense sprint workouts can improve performance for field hockey players. If you are an active player aged 18–30, this study could help you get faster and fitter on the field.
Lahore, Punjab ProvinceAges 18–30 - NCT07285096Recruiting
New quadruple therapy for H. pylori infection
This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.
JinanAges 18–70 - NCT05836207Recruiting
Rewards for quitting cannabis in young adults
This study tests whether offering rewards can help young adults stop using cannabis. You would attend a treatment clinic and provide supervised urine tests twice each week while aiming to quit.
AmsterdamAges 16–22 - NCT06837792RecruitingPhase 2
T-DXd vs hormone therapy for HER2-low advanced breast cancer
This trial compares a targeted antibody-drug conjugate called T-DXd against standard hormone therapy for women with HR+, HER2-low advanced breast cancer that has progressed after first-line endocrine therapy plus a CDK4/6 inhibitor. It aims to see if T-DXd works better than continuing hormone therapy alone.
SeoulAges 19 years+ - NCT06503003Recruiting
Laser therapy for menopause symptoms
This study tests a non-surgical laser treatment to help with vaginal dryness, burning, pain during sex, and other symptoms caused by menopause. The goal is to see if it can safely improve quality of life and sexual health.
Cagliari, CAAges 45–73 - NCT07171606RecruitingPhase 2
Study of a new drug for advanced lung cancer
This trial tests a new drug called SSGJ-706, either alone or with other treatments, for people with advanced non-small cell lung cancer (NSCLC) that has spread or cannot be surgically removed. The goal is to see if it helps shrink or control the cancer.
ShanghaiAges 18–75 - NCT06832904RecruitingPhase 2
Chemo plus two targeted drugs before surgery for HER2+ breast cancer
This trial tests whether giving a combination of two targeted drugs (pyrotinib and trastuzumab) along with standard chemotherapy before surgery can work better for HER2-positive breast cancer. It is for women whose cancer has not spread to distant organs and who have not yet had treatment for their cancer.
HangzhouAges 18–75 - NCT04491929Recruiting
Radiation treatment for colon cancer in the liver using tiny beads
This trial studies a targeted liver radiation procedure that uses tiny radioactive beads to treat colon cancer spread mostly in the liver. It may help people whose liver tumors cannot be removed or treated with other common local treatments, but it has several safety and “screening” checks.
Aarhus N, DanmarkAges 18 years+ - NCT06828380RecruitingPhase 2
Immunotherapy with or without radiation for liver cancer
This trial tests whether using immunotherapy alone works as well as immunotherapy combined with radiation for liver cancer that has spread into major blood vessels. The goal is to find the best treatment option for people with this specific type of advanced liver cancer.
GoyangAges 19 years+ - NCT07173491Recruiting
Music therapy for anxious dental patients having cavity treatment
This trial tests whether listening to music during a single dental visit can reduce anxiety for people with mild to moderate tooth decay who are nervous about dental procedures.
Erzurum, ErzurumAges 18–40 - NCT04458532Recruiting
Exercise program to boost heart health after early breast cancer
This trial studies whether a structured exercise program can improve cardiovascular (heart and blood vessel) health in post-menopausal women after early-stage breast cancer treatment. It specifically targets women who have trouble with exercise and have completed cancer treatment within the last 1 to 5 years.
Hartford, ConnecticutAges 21–80 - NCT07276100RecruitingPhase 2
Fecal transplant to help liver cancer that worsened on first treatment
This trial tests whether transplanting healthy stool bacteria into your gut can help your own immune system fight liver cancer that has stopped responding to the standard first combination treatment (atezolizumab + bevacizumab). It is for patients whose liver cancer has started growing quickly despite that treatment.
Bologna, BOAges 18 years+
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,377 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.